- The weight‑loss drug market is exploding — analysts expect it could hit about $100 billion a year in the next decade, and big pharma is racing to grab market share.
- There’s a major shift from injections to pills: Novo Nordisk and Eli Lilly have secured recent approvals for oral versions of their drugs, and many companies are pushing pill candidates.
- New experimental treatments are showing dramatic results — several drugs report roughly 20–30% body‑weight reductions in trials, plus options like monthly injections are being developed.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.